Popularity and customer preferences for over-the-counter Chinese medicines perceived by community pharmacists in Shanghai and Guangzhou: A questionnaire survey study

Chinese Medicine (United Kingdom)

Volumn 9, Issue 1, 2014, Pages

  Ge, Shuai ^a   He, Tian Tian ^a   Hu, Hao ^a  

^a China Macau University of Science and Technology Zhuhai MUST Science and Technology Research Institute   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; NON PRESCRIPTION DRUG; QING RE; QU DU; UNCLASSIFIED DRUG;

ARTICLE; CHINA; CHINESE MEDICINE; CONSUMER ATTITUDE; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG SAFETY; HEALTH SURVEY; HUMAN; PHARMACIST; QUESTIONNAIRE;

EID: 84908204975     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-9-22     Document Type: Article

References (60)

1. Pandya RN, Jhaveri KS, Vyas FI, Patel VJ. Prevalence, pattern and perceptions of self-medication in medical students. Int J Basic Clin Pharmacol 2013, 2(3):275-280.
2. You JH, Wong FY, Chan FW, Wong EL, Yeoh EK. Public perception on the role of community pharmacists in self-medication and self-care in Hong Kong. BMC Clin Pharmacol 2011, 11(1):19.
3. Baeten S, Van Ourti T, Van Doorslaer E. Rising inequalities in income and health in China: who is left behind?. J Health Econ 2013, 32(6):1214-1229.
4. Yuefeng L, Keqin R, Xiaowei R. Use of and factors associated with self-treatment in China. BMC Public Health 2012, 12:995.
5. Bower AB, Grau SL, Taylor VA. Over-the-counter vs. prescription medications: are consumer perceptions of the consequences of drug instruction non-compliance different?. Int J Consum Res 2012, 37(2):229-233.
6. Chung CH, Lau CH, Chan WK, You HS, Wong LY, Griffiths SM. Use of Chinese and western over-the-counter medications in Hong Kong. Chin Med 2010, 5:41.
7. Ryan M, Yule B. Switching drugs from prescription-only to over-the-counter availability: economic benefits in the United Kingdom. Health Policy 1990, 16(3):233-239.
8. Lynch N, Berry D. Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal products. Complement Ther Med 2007, 15:84-91.
9. Bradley C, Blenkinsopp A. Over the counter drugs: The future for self-medication. BMJ 1996, 312(7034):835-837.
10. Feng Y, Wu Z, Zhou X, Zhou Z, Fan W. Knowledge discovery in traditional Chinese medicine: state of the art and perspectives. Artif Intell Med 2006, 38(3):219-236.
11. Harmsworth K, Lewith GT. Attitudes to traditional Chinese medicine amongst Western trained doctors in the People's Republic of China. Soc Sci Med 2001, 52(1):149-153.
12. Furnham A, Vincent C, Wood R. The health beliefs and behaviors of three groups of complementary medicine and a general practice group of patients. J Altern Complement Med 1995, 1(4):347-359.
13. Chan MF, Mok E, Wong YS, Tong TF, Day MC, Tang CKY, Wong DHC. Attitudes of Hong Kong Chinese to traditional Chinese medicine and western medicine: survey and cluster analysis. Complement Ther Med 2003, 11(2):103-109.
14. Shahrokh LE, Lukaszuk JM, Prawitz AD. Elderly herbal supplement users less satisfied with medical care than nonusers. J Am Diet Assoc 2005, 105(7):1138-1140.
15. Yu WZ. The marketing innovation of the self-medication OTC drugs with reference to the reform of medical treatment. The Proceedings of 2009 International Conference on Information Management, Innovation Management and Industrial Engineering, 26-27 December, 2009, Xi'an 2009, 81-87. IEEE: IEEE.
16. Chan K. Some aspects of toxic contaminants in herbal medicines. Chemosphere 2003, 52(9):1361-1371.
17. Saad B, Azaizeh H, Abu-Hijleh G, Said O. Safety of traditional Arab herbal medicine. Evid Based Complement Alternat Med 2006, 3(4):433-439.
18. Cheng JT. Drug therapy in Chinese traditional medicine. J Clin Pharmacol 2000, 40(5):445-450.
19. Wenzel RG, Sarvis CA, Krause ML. Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Pharmacotherapy 2003, 23:494-505.
20. Chung VC, Ma PH, Lau CH, Wong SY, Yeoh EK, Griffiths SM. Views on traditional Chinese medicine amongst Chinese population: a systematic review of qualitative and quantitative studies. Health Expect 2012, May 31. doi:10.1111/j.1369-7625.2012.00794.x. [Epub ahead of print].
21. Hon EK, Lee K, Tse HM, Lam LN, Tam KC, Chu KM, Lee V, Lau C, Leung TF. A survey of attitudes to traditional Chinese medicine in Hong Kong pharmacy students. Complement Ther Med 2004, 12(1):51-56.
22. Chung VC, Ma PH, Tang TS, Lau CH, Kim JH, Griffiths SM. Do patients tell their clinicians they are using both prescribed and over the counter allopathic and traditional medicines?. Eur J Integr Med 2011, 3(4):289-298.
23. Li X, Yang G, Li X, Zhang Y, Yang J, Chang J, Sun X, Zhou X, Guo Y, Xu Y, Liu J, Bensoussan A. Traditional Chinese medicine in cancer care: a review of controlled clinical studies published in Chinese. PLoS One 2013, 8(4):e60338.
24. Liao YH, Lin CC, Li TC, Lin JG. Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan. BMC Complement Altern Med 2013, 12:146.
25. Li GD, Wu XF. Feasibility and design about OTC pharmacies in hospitals. Guo Ji Yi Yao Wei Sheng Dao Bao 2004, 10(8):143-145.
26. Company MDC. Market research of clinical medication in hospitals of traditional Chinese medicine in 2004 2004, Beijing: MDC Company.
27. Smith F. The extended role of the community pharmacist: implications for the primary health care team. J Soc Admin Pharm 1990, 7:101-110.
28. Chan TYK, Lee KKC, Critchley JAJH. The needs and sources of drug information among pharmacists in Hong Kong. J Clin Pharm Ther 1996, 21(5):325-330.
29. Fang Y, Yang S, Zhou S, Jiang M, Liu J. Community pharmacy practice in China: past, present and future. Int J Clin Pharm 2013, 35(4):520-528.
30. People's Government of Guangdong Province: The Eleventh Five Year Development Plan of the Traditional Chinese Medicine in Guangdong. [http://www.gd.gov.cn/govpub/fzgh/hygh/0200702070036.htm].
31. Shanghai Municipal Commission of Health and Family Planning: The Twelfth Five Year Development Plan of the Traditional Chinese Medicine in Shanghai. [http://www.wsjsw.gov.cn/wsj/n429/n432/n1485/n1496/u1ai80358.html].
32. Guangzhou Municipal Development Reform Commission: The Twelfth Five Year Development Plan of the Traditional Chinese Medicine in Guangzhou. [http://www.gzplan.gov.cn/publicfiles/business/htmlfiles/gzplan/qtwj/201402/2608403.html].
33. Chen XQ. Main lists of time-honored Chinese medicine companies in business after the Liberation. Zhongguo Yao Xue Za Zhi 1999, 34(9):632.
34. Cialdini RB. Influence 2009, New York: HarperCollins e-books: New York Press.
35. Deval H, Mantel SP, Kardes FR, Posavac SS. How naïve theories drive opposing inferences from the same information. J Consum Res 2013, 39:1185-1201.
36. Guan X, Liang H, Xue Y, Shi L. An analysis of China's national essential medicines policy. J Public Health Policy 2011, 32(3):305-319.
37. Baruch Y. Response rates in academic studies-a comparative analysis. Hum Relat 1999, 52:421-434.
38. Cao JJ. Study on pharmacodynamics of Xiao-chai-hu tablets. Zhongguo Lin Chuang Yao Li Xue Za Zhi 2010, 26(2):88-89.
39. China Food and Drug Administration: Notice about opinion of the establishment and implementation of National Essential Drugs System. [http://www.sda.gov.cn/WS01/CL0611/40753.html].
40. Li BM. The developing trend of the OTC market and research of the main popular OTC brand products in China. Heilongjiang Yi Xue Za Zhi 2014, in press.
41. Cheung F. TCM: Made in China. Nature 2011, 480(7378):S82-S83.
42. Kim JH, Kwong EM, Chung VC, Lee JC, Wong T, Goggins WB. Acute adverse events from over-the-counter Chinese herbal medicines: a population-based survey of Hong Kong Chinese. BMC Complement Altern Med 2013, 13:336.
43. Boullata JI, Nace AM. Safety issues with herbal medicine. Pharmacotherapy 2000, 20(3):257-269.
44. Luo H, Li Q, Flower A, Lewith G, Liu JP. Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials. J Ethnopharmacol 2012, 140(3):555-567.
45. Jha V, Rathi M. Natural medicines causing acute kidney injury. Semin Nephrol 2008, 28(4):416-428.
46. Kelvin C. An overview on safety issues of interactions between traditional herbal medicines and pharmaceutical medicines. Boletín Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas 2008, 7(6):312-331.
47. Raynor DK, Dickinson R, Knapp P, Long AF, Nicolson DJ. Buyer beware? Does the information provided with herbal products available over the counter enable safe use?. BMC Med 2011, 9:94.
48. Hughes L, Whittlesea C, Luscombe D. Patients' knowledge and perceptions of the side-effects of OTC medication. J Clin Pharm Ther 2002, 27(4):243-248.
49. Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010, 55(6):515-525.
50. Gratus C, Wilson S, Greenfield SM, Damery SL, Warmington SA, Grieve R, Steven NM, Routledge P. The use of herbal medicines by people with cancer. BMC Complement Altern Med 2009, 9:14.
51. Xu Q, Bauer R, Hendry BM, Fan TP, Zhao Z, Duez P, Simmonds MS, Witt CM, Lu A, Robinson N, Guo DA, Hylands PJ. The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med 2013, 13:132.
52. Mhatre SSS. Over-the-counter medication use and its impact on quality of life of the elderly. Value Health 2012, 15:A203.
53. Song PP, Gao JJ, Kokudo N, Tang W. Standardization of traditional Chinese medicine and evaluation of evidence from its clinical practice. Drug Discov Ther 2011, 5(6):261-265.
54. Shang HC, Li YP, Chen J, Zhang JH, Zhang BL. New trends for clinical research of traditional Chinese medicine in China. Chin Med J (Engl) 2008, 121(11):1050-1051.
55. Kim JH, Chung CHV, Lau CH, Goggins WB, Lau JT, Griffiths S. Adverse events and poisonings from over-the-counter Traditional Chinese Medicine: A population-based survey for improving consumer safety. Research Fund for the Control of Infectious Diseases 2012, [http://fhbgrants.netsoft.net/english/funded_list/funded_list_detail.php?id=1018&no=331].
56. Fan TP, Deal G, Koo HL, Rees D, Sun H, Chen S, Dou JH, Makarov VG, Pozharitskaya ON, Shikov AN, Kim YS, Huang YT, Chang YS, Jia W, Dias A, Wong VC, Chan K. Future development of global regulations of Chinese herbal products. J Ethnopharmacol 2012, 140(3):568-586.
57. Liu GG, Zhao Z, Cai R, Yamada T. Equity in health care access to: assessing the urban health insurance reform in China. Soc Sci Med 2002, 55(10):1779-1794.
58. Chung VC, Ma PH, Wang HH, Wang JJ, Hong LC, Wei X, Wong SY, Tang JL, Griffiths SM. Integrating traditional Chinese medicine services in community health centers: insights into utilization patterns in the Pearl River Region of China. Evid Based Complement Alternat Med 2013, 426360.
59. Cai Y, Mao Z, Xu B, Wu B. Factors associated with traditional Chinese medicine utilization among urban community health centers in Hubei Province of China.Asia-Pacific. J Public Health 2013, published online before print, doi:10.1177/1010539513491415.
60. Cho JH, Lee TJ. The factors contributing to expenditures on over-the-counter drugs in South Korea. Value in Health Regional Issues 2013, 2(1):147-151.